Cancer medicines

Degarelix

Degarelix

A GnRH antagonist lowering testosterone in prostate cancer.

Sources checked · Introductory guide

On this page

How it works

It blocks GnRH receptors to suppress androgen production.[3]

Where it is used

Used for androgen deprivation in advanced prostate cancer. It acts differently from GnRH agonists.[1]

Key safety points

Discuss injection-site reactions and bone health. Disclose rhythm problems and medicines; fainting, palpitations or breathlessness need urgent assessment.[2]

Questions for your care team

  • Why was this drug chosen, and when are PSA and testosterone checked?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Degarelix (opens in a new tab)
  2. MedlinePlus · Degarelix (opens in a new tab)
  3. NCI Drug Dictionary · Degarelix (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Degarelix | Cancer Encyclopedia | My Chemo Diary